Full Text View
Tabular View
Study Results
Related Studies
A Study of Adalimumab for the Induction of Clinical Remission in Japanese Subjects With Crohn's Disease
This study has been completed.
Study NCT00445939.   Last updated on April 7, 2009.
Information provided by Abbott
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Crohn's Disease
Additional conditions recognized in this trial
Crohn Disease
Enteritis
Ileitis
More general conditions related to this trial
Digestive System Diseases
Gastroenteritis
Gastrointestinal Diseases
Ileal Diseases
Inflammatory Bowel Diseases
Intestinal Diseases
Interventions listed in this trial
adalimumab
placebo
More general drug interventions related to this trial
Anti-Inflammatory Agents
Antirheumatic Agents
Pharmacologic Actions
Therapeutic Uses
Sponsors listed in this trial
Abbott
Abbott Japan Co.,Ltd
Eisai Limited


U.S. National Library of Medicine,  Contact Help Desk
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services